Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO and IARC have joined forces to improve cancer prevention worldwide.

ESMO is supporting IARC in the development of their online learning platform which integrates all research for cancer prevention in one easy-to-access point.

ESMO-Cancer-Prevention-1000x1000-World-Cancer-Report

IARC’s  World Cancer Report Updates Learning Platform offers freely accessible learning material based on selected content from the IARC 2020 World Cancer Report, the most comprehensive resource on cancer prevention published every five years. The goal of the platform is to turn the latest research into policy and practical measures to help stakeholders in control cancer. It is also designed to enlarge the base of doctors who are properly educated and trained in key prevention measures, allowing them to provide guidance to patients as well as to act as role models.

As this is a freely accessible resource, with vital information on cancer prevention and research, ESMO would encourage you to register for the portal, in order to receive direct updates, including those on live events and self-paced resources.

Upcoming webinars

The next webinars in the series will take place in October 2021 on the topic of Primary cancer prevention – future challenges and opportunities. Further details will be added here once they are available. 

Access to on demand webinars and other resources related to each webinar:

WCR-Webinar-Series-Covid-19-and-Cancer-Screening

What are the consequences of COVID-19 for cancer screening? What challenges have been encountered by countries? What could be turned into an opportunity, and what lessons have been learned? This webinar addressed these questions and provided examples from low-income and high-income countries. Please note that to view the recording of this webinar you will be asked to enroll with the IARC learning platform.

WCR-Webinar-Series-HPV-Vaccination

Data are rapidly accruing on the impressive effectiveness of HPV vaccination programmes, including strong herd immunity effects and reduction in cervical cancer rates. This webinar presents the impact of HPV vaccination in Australia, which implemented one of the earliest and most successful vaccination programmes. It also provides an up-to-date picture of global progress in the implementation of HPV vaccination, with a focus on challenges in low- and middle-income countries.

WCR-Webinar-Series-Obesity-and-Cancer

Obesity is an established risk factor for cancer at 13 anatomical sites. This webinar provides an overview of current understanding on the epidemiology and biology of the obesity–cancer relationship as well as important outstanding research questions. It also addresses the challenges of current and future interventions aimed at breaking the obesity–cancer link and explores what can be done at both the societal and individual level to tackle the obesity crisis and its impact on the cancer burden.

WCR-Webinar-Series-Social-Inequalities-and-Cancer

People who have lower socioeconomic status or are part of marginalized groups tend to have a higher incidence of certain types of cancers and higher mortality from most cancer types compared with people who have higher socioeconomic status. This webinar provides an overview of how the phenomenon of inequalities in cancer is shaped, and of how socioeconomic inequalities affect all countries worldwide and all citizens within each country. The experts also touch on strategies to tackle inequality in cancer.

About the IARC World Cancer Report

The IARC 2020 World Cancer Report: Cancer Research for Cancer Preventionnotes that cancer is the ‘first or second cause of premature death (ages 30-69) in 134 of 183 countries’.

According to the IARC Global Cancer Observatory  cancer is expected to increase from 2018 to 2040, from an incidence of 18.1 million to 29.5 million with growth in the number of deaths from 9.6 million to 16.4 million. A main message of the IARC report is that prevention offers the most cost-effective long-term strategy for the control of cancer. The report offers a wealth of knowledge including ‘the most comprehensive overview of relevant research available to date, ranging from descriptive etiology, cellular and molecular biology, toxicology and pathology through to behavioural and social science. Key chapters include discussions on the impact of inequalities in cancer, vaccination and screening, genomic individual susceptibility to cancer and the finer identification of those at risk, which may allow ‘precision cancer prevention’.’ The section on ‘inequalities that affect cancer prevention’ is new in the 2020 edition and explains how socioeconomic inequalities can limit cancer prevention impact. The IARC report is complemented by other publications such as the  WHO Classification of Tumours series (also known as the WHO Blue Books); the IARC volumes of Cancer Incidence in Five Continents, and the associated GLOBOCAN database document data on incidence, prevalence, mortality, and trends for multiple cancer types accessible online through the IARC Global Cancer Observatory.

The IARC report provides the most up-to-date science on cancer, and was published at the same time as the WHO 2020 Report on Cancer: setting priorities, investing wisely and providing care for all which indicates how that science can be translated into public policies.

The WHO and IARC reports provide a reliable resource for ESMO members for evidence-based data on the burden of cancer, its prevention, and public policy recommendations governments and health authorities can implement to save lives.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings